Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan

Nephrology Dialysis Transplantation

Volumn 15, Issue 7, 2000, Pages 1008-1013

  Hsieh, Ming Chia ^a   Lin, Shiu Ru ^a   Hsieh, Tusty Jiuan ^a   Hsu, Chin Hsun ^a   Chen, Hung Chun ^a   Shin, Shyi Jang ^a   Tsai, Juei Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ACE genotype; Diabetic nephropathy; Type 2 diabetes

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIALYSIS; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TAIWAN;

EID: 0034083529     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.7.1008     Document Type: Article

References (42)

1. Pan XR, Yang WY, Li GW, Liu J. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997; 20: 1664-1669
2. Chou P, Chen HH, Hsiao KJ. Community-based epidemiological study on diabetes in Pu-Li, Taiwan. Diabetes Care 1992; 15: 81-89
3. Rewers M, Hamman RF. Risk factors for non-insulin-dependent diabetes. In: National Diabetes Data Group, Diabetes in America (2nd edn). National Institutes of Health/NIDDK, Bethesda, 1995; 179-220
4. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin dependent diabetes. In: National Diabetes Data Group, Diabetes in America (2nd edn). National Institutes of Health/NIDDK, Bethesda, 1995; 47-68
5. Lai YH, Hwang SJ, Yang WC, and the dialysis surveillance committee. 1997 National Dialysis Surveillance in Taiwan. Acta Nephrol, Society of Nephrology, ROC 1997; 11: 177-214
6. Li LS. End-stage renal disease in China. Kidney Int 1996; 49: 287-301
7. Tarnow L. Genetic pattern in diabetic nephropathy. Nephrol Dial Transplant 1996; 11: 410-412
8. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1990; 33: 438-443
9. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin dependent diabetes mellitus. Am J Kidney Dis 1995; 25: 710-713
10. Torlone E, Rambotti AM, Perriello G et al. ACE-inhibition increased hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 1991; 34: 119-125
11. Jauch K-W, Hartl W, Guentler B, Wicklmayr M, Rett K, Dietze G. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1987; 17: 448-454
12. Marre M, Bernadet P, Gallois Y et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-388
13. Rigat B, Hubert C, Alhene-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme level. J Clin Invest 1990; 86: 1343-1346
14. Tsutaya S, Kitaya H, Saito Y et al. Angiotesin converting enzyme gene polymorphism and its enzyme activity in serum in young Japanese females. Tohoku J Exp Med 1997; 182: 151-155
15. Nakai K, Itoh C, Miura Y et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90; 2199-2202
16. Tiret L, Rigat B, Visvikis S et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205
17. Cambien F. The angiotensin-converling, enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet 1994; 46: 94-101
18. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in the relationship of an angiotensin I-converting enzyme activity. Hypertension 1996; 27: 62-66
19. Barley J, Blockwood A, Carter ND. Angiotensin converting enzyme insertion/deletion polymorphism. Association with ethnic origin. J Hypertens 1994; 12: 955-957
20. Doi Y, Yoshizumi H, Yoshinari M et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39: 97-102
21. Gwon HC, Kim DK, Kim JW et al. Polymorphism of angiotensin converting enzyme (ACE) gene is associated with plasma plasminogen activator inhibitor-1 level. J Hypertens 1996; 14 [Suppl]:S27
22. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 559: 641-644
23. Schunkert H, Hense HW, Holner SR et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-4638
24. Schmidt S, Schone N, Ritz E. The Diabetic nephropathy study group. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995; 47: 1176-1181
25. Mizuiri S, Hemmi H, Inoue A et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70: 455-459
26. Ohno T, Kawazu S, Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1996; 45: 218-222
27. Smith T, Panagiotopoulos S, Aldred P, Baker L, Jacklin C, Jerums G. Angiotensin converting enzyme (ACE) gene polymorphism in NIDDM with elevated albuminuria. J Am Soc Nephrol 1995; 6: 456
28. Fujisawa T, Ikegami H, Shen G-O et al. Angiotensin-I converting enzyme polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18: 983-985
29. Ha SK, Seo JK. Insertion/deletion polymorphism in ACE gene as predictor for progression of diabetic nephropathy. Kidney Int [Suppl] 1997; 60: 28-32
30. Zingone A, Dominijanni A, Mele E et al. Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet 1994; 94: 207-209
31. Huang XH, Rantalaiho V, Wirta O et al. Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet 1998; 102: 372-378.
32. Jeffers BW, Estacio RO, Raynolds MV, Schrier RW. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 1997; 52: 473-477
33. Lane PH, Stefes MW, Mauer M. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 1992; 41: 581-586
34. Ritz E, Keller CK, Bergis HK, Siebels M. Renal involvement in type II diabetes. Curr Opin Nephrol Hypertens 1994; 3: 137-144
35. Parving HH, Gall MA, Skott P. Prevalence and cause of albuminuria in non-insulin dependent diabetic patients. Kidney Int 1987; 41: 758-762
36. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673-689
37. Kunz R, Bork JP, Fritsche L, Ringel J, Sharma AM. Association between the angiotensin-converting enzyme insertion/deletion polymorphism and diabetic nephropathy. A methodologic appraisal and systematic review. J Am Soc Nephrol 1998; 9: 1653-1663
38. Tarnow L, Gluud C, Parving HH. Diabetic nephropathy and the insertion/deletion polymorphism of angiotensin-converting enzyme gene. Nephrol Dial Transplant 1998; 13: 1125-1130
39. Yoshida H, Kuriyama S, Atsumi Y et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50: 657-664
40. Huang XH, Rantalaiho V, Wirta O et al. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albumin-uria in patients with NIDDM followed up for 9 years. Nephron 1998; 80: 17-24
41. Mauer M, Mogensen CE, Friedman EA. Diabetic nephropathy. In: Schrier RW, Gottshelf CW, eds, Disease of the Kidney (6th edn). Saunders, Boston; 1996
42. Zmohrndrn VR, Christensen CK. Predicting diabetic nephropathy in insulin dependent patients. N Engl J Med 1984; 311: 89-93